Showing results (1-10 of 90) with videos related to
Sort By:
Pageof 9
Anti-Cancer Agents in Medicinal Chemistry|January 9, 2026
Molecular Simulation, Pharmacophore Mapping, and 3D QSAR Modeling on Chromene-Based SERDsSuresh Thareja, Sanjana BishtMedical Oncology (Northwood, London, England)|May 16, 2023
Elacestrant: a new FDA-approved SERD for the treatment of breast cancerNeha Bhatia, Suresh TharejaAnti-Cancer Agents in Medicinal Chemistry|August 18, 2025
Gaussian-based 3D-QSAR and Pharmacophore Mapping Studies of Indole Derivatives as Aromatase InhibitorsNeha Bhatia, Suresh TharejaChemistry & Biodiversity|June 30, 2026
Structure-Based De Novo Design of Novel Dual DPP IV and PTP 1B Inhibitors (DDPI's)Yogesh Singh, Suresh TharejaBioorganic Chemistry|July 13, 2024
Aromatase inhibitors for the treatment of breast cancer: An overview (2019-2023)Neha Bhatia, Suresh TharejaPlos One|April 12, 2017
Structure based comprehensive modelling, spatial fingerprints mapping and ADME screening of curcumin analogues as novel ALR2 inhibitorsSant Kumar Verma, Suresh TharejaArtificial Cells, Nanomedicine, and Biotechnology|February 21, 2019
In vitro and in vivo characterization of pharmaceutical nanocarriers used for drug deliveryAkhlesh K Jain, Suresh TharejaMini Reviews in Medicinal Chemistry|March 1, 2026
Inavolisib-based Combination Therapy for the Treatment of PIK3CAMutated HR+/HER2- Breast Cancer: An OverviewSushmita Bhatia, Neha Bhatia, Suresh TharejaEuropean Journal of Medicinal Chemistry|May 10, 2023
Selective Estrogen receptor degraders (SERDs) for the treatment of breast cancer: An overviewNeha Bhatia, Shreejita Hazra, Suresh TharejaInternational Review of Cell and Molecular Biology|February 12, 2025
Identification of cell-free circulating epigenomic biomarkers for early diagnosis and response to therapies in breast cancer patientsPooja Ratre, Suresh Thareja, Pradyumna Kumar MishraPageof 9